Have a personal or library account? Click to login
The Impact of Initial Public Offering (Ipo) on the Financial Performance of Algerian Companies: Case Study – Biopharm Cover

The Impact of Initial Public Offering (Ipo) on the Financial Performance of Algerian Companies: Case Study – Biopharm

Open Access
|Dec 2025

Abstract

The present research paper aims to identify the impact of the Initial Public offering (Ipo) on the financial performance of Biopharm company. This is achieved through the calculation of several key indicators such as turnover evolution, Return on Assets (ROA), Return on Equity (ROE), debt ratio, cost of debt and dividend payout ratio (DPR). A comparison is made between these indicators over two periods: the first refers to the pre-IPo period, while the second covers the post-IPo period. on the basis of these six indicators, the impact of the IPo on Biopharm appears mixed, i.e. there is not a definite overall impact. This suggests that the IPo was not a truly advantageous decision for the company. Furthermore, the Algiers stock exchange does not appear to make a positive contribution to listed companies. This finding is in line with the criticism regularly levelled at the Algiers stock exchange for its lack of dynamism, which is detrimental to listed companies.

DOI: https://doi.org/10.2478/bsaft-2025-0018 | Journal eISSN: 3100-5098 | Journal ISSN: 3100-508X
Language: English
Page range: 158 - 172
Published on: Dec 16, 2025
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2025 Mounira BOUHAOUAS, Tarek OUAHABI, published by Nicolae Balcescu Land Forces Academy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.